LLY
Eli Lilly & Co.
NYSE · usd
Eli Lilly & Co. (LLY) trades at $1,273.46 (-2.54%) as of 4:55:35 PM EDT on Oct 23, 2026, +7.75% over the past month. Market cap is $1.16T, with 2.9 days to cover in short interest.
Stock performance
How Eli Lilly & Co. (LLY) stock has performed from one day to one year, with its 52-week range.
- 1D
- -2.54%
- 1W
- +1.31%
- 1M
- +7.75%
- YTD
- +18.50%
- 1Y
- +54.27%
- 52-wk range
- $809.63 – $1,321.21
Key statistics
Today's trading snapshot for LLY: day range, open, previous close, volume and market cap.
- Day range
- $1,257.62 – $1,307.92
- Open
- $1,304.15
- Prev close
- $1,306.69
- Volume
- 2.27M
- Market cap
- $1.16T
- Shares out
- 941.36M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Eli Lilly & Co.: P/E, P/S, P/B, ROE and more.
- P/E
- 43.60
- P/S
- 14.62
- P/B
- 34.38
- P/FCF
- 64.03
- ROE
- 78.8%
- ROA
- 18.8%
- Debt/Equity
- 1.62
- Div yield
- 0.50%
As of Oct 22, 2026
8-K filings
Material corporate events Eli Lilly & Co. has disclosed to the SEC on Form 8-K.
- Earnings and performanceAug 5, 2026
Attached hereto as Exhibit 99.1 and incorporated by reference into this Item 2.02 is a copy of the press release, dated August 5, 2026, announcing the financial results of Eli Lilly and Company for the quarter ended June 30, 2026.
- Equity activityMay 20, 2026
The Notes were sold pursuant to an underwriting agreement by and among the Company, Morgan Stanley & Co. LLC, Citigroup Global Markets Inc., Deutsche Bank Securities Inc. and Goldman Sachs & Co. LLC, as representatives of the several underwriters named therein.
- Shareholder activismMay 7, 2026
By the following vote, a shareholder proposal requesting the adoption of a policy and amendment to the bylaws to require an independent board chair was not approved: For 257,292,684, Against 505,068,416, Abstain 2,407,581.
- Earnings and performanceApr 30, 2026
Attached hereto as Exhibit 99.1 and incorporated by reference into this Item 2.02 is a copy of the press release, dated April 30, 2026, announcing the financial results of Eli Lilly and Company for the quarter ended March 31, 2026.
- Earnings and performanceFeb 4, 2026
Attached hereto as Exhibit 99.1 and incorporated by reference into this Item 2.02 is a copy of the press release, dated February 4, 2026, announcing the financial results of Eli Lilly and Company for the quarter and year ended December 31, 2025.
Dividend history and stock splits
Eli Lilly & Co.'s recent dividend payments and stock splits.
Dividends
- $1.73ex-div Aug 14, 2026
- $1.73ex-div May 15, 2026
- $1.73ex-div Feb 13, 2026
- $1.50ex-div Nov 14, 2025
Splits
No recent splits.
LLY short interest
How heavily LLY is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 2.9
- Short interest
- 7.04M
- Avg volume
- 2.4M
As of · reported to FINRA twice monthly.
LLY news
The latest news and headlines about Eli Lilly & Co. (LLY).
- 2 Growth Stocks to Hold for the Next Decade (Hint: These Aren’t AI Stocks)positiveThe Motley Fool· Oct 23, 2026
- Facing Investing FearspositiveThe Motley Fool· Oct 23, 2026
- AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleasenegativeZacks Investment Research· Oct 23, 2026
- Why Healthcare ETFs Are Hovering Around One-Year HighspositiveZacks Investment Research· Oct 23, 2026
- Should Defiance Large Cap ex-Mag 7 ETF (XMAG) Be on Your Investing Radar?neutralZacks Investment Research· Oct 23, 2026
Frequently asked questions
What is the Eli Lilly & Co. (LLY) stock price today?
Eli Lilly & Co. (LLY) is trading at $1,273.46 (-2.54% on the day) as of 4:55:35 PM EDT on Oct 23, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Eli Lilly & Co.?
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for…
What is the short interest in LLY?
As of Sep 30, 2026, LLY has 7.04M shares short and 2.9 days to cover.
Does Eli Lilly & Co. (LLY) pay a dividend?
Yes. Eli Lilly & Co. (LLY)'s most recent dividend was $1.73 per share, with an ex-dividend date of Aug 14, 2026. Full LLY dividend history is available from the Massive API.
What exchange is LLY listed on?
Eli Lilly & Co. (LLY) trades on NYSE in USD, in the PHARMACEUTICAL PREPARATIONS industry.
Build with AI
Build an analysis of LLY with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a LLY analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.